Preventing Pharmageddon: Treatment Access for Noncommunicable Diseases
CFR Senior Fellow Thomas Bollyky argues that new strategies are needed to address the latest treatment-access crisis over patented medications, particularly as noncommunicable diseases continue to rapidly emerge in low- and middle-income countries.
